Comparison of Pharmacokinetic Parameters and Biodistribution of Full-Size Antibodies and Nanoantibodies Specific to Human PD-L1
ETHICS APPROVAL
AND CONSENT TO PARTICIPATE
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Petersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre “Kurchatov Institute” (Аug. 30, 2024, no. 240801).
CONFLICT OF INTEREST
The authors of this work declare that they have no conflicts of interest.
Comments (0)